The Agenzia Italiana Del Farmaco Has Approved Genenta Science's New Phase 1 Trial For Metastatic Renal Cell Cancer For Genenta's Flagship Product, Temferon
The Agenzia Italiana Del Farmaco Has Approved Genenta Science's New Phase 1 Trial For Metastatic Renal Cell Cancer For Genenta's Flagship Product, Temferon
意大利藥品管理局已批准Genenta Science針對轉移性腎臟細胞癌的新一期試驗，用於Genenta的旗艦產品Temferon
The Agenzia Italiana Del Farmaco Has Approved Genenta Science's New Phase 1 Trial For Metastatic Renal Cell Cancer For Genenta's Flagship Product, Temferon
意大利藥品管理局已批准Genenta Science針對轉移性腎臟細胞癌的新一期試驗，用於Genenta的旗艦產品Temferon
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間